Cresset Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Cresset Asset Management's PFE Position: Q2 2026 in Review
Cresset Asset Management increased its Pfizer (PFE) stake by 1.3% in Q2 2026, buying an estimated $208K and bringing the position to 634,638 shares worth $15.3M. The position accounts for 0.06% of the portfolio, ranked #206.
Cresset Asset Management first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $28M in Q3 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cresset Asset Management held 634,638 shares of Pfizer worth $15.3M as of Q2 2026.
- Cresset Asset Management bought 7,943 Pfizer shares in Q2 2026, an estimated $208K.
- Pfizer made up 0.06% of Cresset Asset Management's portfolio in Q2 2026, its #206 holding.
- Cresset Asset Management first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's Pfizer position peaked at $28M in Q3 2024.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.